Unleashing the therapeutic potential of human kallikrein-related serine proteases
Top Cited Papers
- 20 February 2015
- journal article
- review article
- Published by Springer Nature in Nature Reviews Drug Discovery
- Vol. 14 (3) , 183-202
Abstract
Tissue kallikreins (KLKs) constitute a family of 15 secreted serine proteases that are encoded by the largest protease gene cluster in the human genome. KLKs were traditionally known for their clinical applicability as cancer markers — for instance, KLK3 (also known as prostate-specific antigen) is a marker for prostate cancer. The field of KLK research has recently blossomed with the development of KLK-knockout models and the elucidation of the 3D structures of several KLKs. Novel pathophysiological roles for these proteases have recently been assigned in various tissues, such as the airway, cardiovascular system, tooth, skin and brain tissues. The promise of KLKs as therapeutic targets in various pathologies — including skin diseases, hereditary angioedema, neurodegeneration, inflammation and cancer — is emerging. Systematic efforts for the development of the first generation of KLK-based inhibitors as candidate therapeutics have already been initiated.Keywords
This publication has 226 references indexed in Scilit:
- Inhibition of Transcription Factor Specificity Protein 1 Alters the Gene Expression Profile of Keratinocytes Leading to Upregulation of Kallikrein-Related Peptidases and Thymic Stromal LymphopoietinJournal of Investigative Dermatology, 2011
- Neuropsin cleaves EphB2 in the amygdala to control anxietyNature, 2011
- TLR2 Expression Is Increased in Rosacea and Stimulates Enhanced Serine Protease Production by KeratinocytesJournal of Investigative Dermatology, 2011
- Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs)Biochimie, 2010
- Matriptase initiates activation of epidermal pro-kallikrein and disease onset in a mouse model of Netherton syndromeNature Genetics, 2010
- Kallikrein Expression and Cathelicidin Processing Are Independently Controlled in Keratinocytes by Calcium, Vitamin D3, and Retinoic AcidJournal of Investigative Dermatology, 2010
- Optimization of peptide-based inhibitors of prostate-specific antigen (PSA) as targeted imaging agents for prostate cancerBioorganic & Medicinal Chemistry, 2009
- The lupus-susceptibility gene kallikrein downmodulates antibody-mediated glomerulonephritisGenes & Immunity, 2009
- Potent and Selective Peptidyl Boronic Acid Inhibitors of the Serine Protease Prostate-Specific AntigenChemistry & Biology, 2008
- Neuregulin 1 in neural development, synaptic plasticity and schizophreniaNature Reviews Neuroscience, 2008